{"schema_version":"secwatch.filing_event.v1","accession":"0001230245-26-000005","form_type":"8-K","ticker":"PIPR","cik":"0001230245","company_name":"PIPER SANDLER COMPANIES","filed_at":"2026-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.667519+00:00","generated_at":"2026-05-16T04:49:40.158748+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Piper Sandler elects Stuart M. Essig to board, effective Feb 4, 2026","bullets":["Essig was CEO of Integra LifeSciences (1997-2012), growing revenue from ~$15M to $1.6B.","Board expands to 10 directors; Essig appointed to Audit Committee.","Compensation: pro-rated $100K cash retainer, $60K initial equity, $150K annual equity after 2026 meeting.","Essig also serves on IDEXX Laboratories board; previously healthcare M&A banker at Goldman Sachs."],"urls":{"canonical":"https://secwatch.observer/filing/0001230245-26-000005","json":"https://secwatch.observer/filing/0001230245-26-000005.json","markdown":"https://secwatch.observer/filing/0001230245-26-000005.md","text":"https://secwatch.observer/filing/0001230245-26-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1230245/000123024526000005/0001230245-26-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1230245/000123024526000005/pipr-20260204.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:49:40.158748+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}